The growth hormone (GH) and insulin-like factor 1 (IGF-1) growth axis is integral to growth, metabolism and tissue repair. This pathway involves binding of GH to the GH receptor and activation of the transcription factor, Stat5b, leading to nuclear transclocation, interaction with DNA binding sites in chromatin and stimulation of IGF-1 transcription. Stat5b binding sites have been determined experimentally by previous research but are all found far from the IGF-1 promoters and the mechanism by which Stat5b binding initiates IGF-1 gene transcription is currently unknown. Since no system for studying this process currently exists, the goal of this project is to create a cell-based transcriptional test system by placing the rat IGF-1 locus in the form of a linearized bacterial artificial chromosome (BAC) into mammalian cell line. The transgene then will be studied for GH regulation, Stat5b binding to specific DNA sequences, and the long distance interactions between Stat5b binding sites and the IGF-1 gene promoters that are for activating IGF-1 gene transcription. If successful, this project will help to answer fundamental questions about the GH IGF-1 growth axis, more specifically the role of Stat5b.
Introduction
Physiology of Growth Hormone. Growth hormone (GH) is produced and secreted from the anterior pituitary gland. 1 GH promotes growth throughout childhood and plays a role in metabolism and tissue repair throughout life. 2 Having an over-abundance of circulating GH can cause disorders such as gigantism in children and acromegaly in adults. 3, 4 In contrast, GH deficiency in children causes severe growth defects, which can be treated with exogenous GH 5 . The GH-mediated growth axis is relatively well conserved among vertebrates and highly conserved among mammals. 6 Growth Hormone Receptor and Signaling. GH acts by binding and activating a transmembrane receptor. The growth hormone receptor (GHR) is a member of the class 1 cytokine family and it has an extracellular N-terminal domain, a single transmembrane α-helix, and a C-terminal intracellular segment. 7 The intracellular part of the GHR is associated with the protein tyrosine kinase, Janus kinase 2 (JAK2). Upon binding of GH to the extracellular part of the GHR, the receptor undergoes a conformational change, which leads to activation of JAK2, and phosphorylation of multiple tyrosine residues within the intracellular part of the GHR by JAK2. 8 These phospho-tyrosine residues function as docking sites for signaling proteins that mediate the biological effects of the activated GHR ( Figure 1 ). As seen with defects in GH, mutations in the GHR also lead to growth deficiency and short stature, but these cannot be treated successfully with GH. Stats have a similar structure. The unique structure of the protein arises from the DNA-Binding Domain, the region which allows it to bind DNA (Blue), the SH2 domain, the region which allows it to bind to other activated Stats (Red, Left), and the transactivation domain (TAD) which allows it to interact with proteins involved in transcription (Red, Right).
activated cytokine receptors, including the GHR. Stats are latent in the cytoplasm until they are recruited to the binding sites that contain phosphorylated tyrosine residues of activated cytokine receptors, where they undergo phosphorylation on a single critical tyrosine residue (Figure 1 ). 10 This leads to Stat activation through separate steps including dissociation from the receptor, dimerization, and translocation into the nucleus.
In the nucleus, activated Stats bind to specific DNA sequences at regulatory sites on target genes, setting into motion events that stimulate gene transcription. Stats all have a general modular structure, which includes a coiled-coil region, a DNA binding domain, a SH2 domain, and a transactivation domain (TAD) (   Figure 2 ). 11 The DNA binding domain is the region of the protein which allows the Stat to bind to the DNA. The region of the protein which allows the Stats to form dimers is the SH2 domain. The TAD is the part of the protein which recognizes specific DNA sequences and allows it to interact with other proteins that initiate transcription. Among the several Stats that are activated by the GHR and JAK2, Stat5b appears to be the critical growth regulating transcription factor 12 as inactivating mutations also have been found in individuals with growth deficiency and short stature.
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Growth Hormone Signaling and IGF-I. Insulin-like growth factor-I (IGF-I) is a 70-amino acid circulating peptide that also is critical for growth during childhood, and plays an important role in tissue maintenance and repair in the adult. 14 The production of IGF-1 is under control of GH, and rare defects in IGF-I also cause severe growth failure in children. 15 GH promotes synthesis of IGF-I by stimulating IGF-I gene expression through induction of IGF-I gene transcription, 16 a process also mediated by Stat5b. The focus of this research project will be on how GH via Stat5b activates IGF-I gene transcription. Subsequently, the Stat5b binding sites will be removed in order to determine which are most important in mediating GH stimulated transcriptional activation. We could then begin to answer questions about the mechanism of GH regulation of IGF-1 transcription and the role Stat5b plays. transformed with ligations and kept on ice for 30 min. The E.coli was "heat-shocked" at 42°C for 30 sec, antibiotic free media was added and E. coli were incubated for 1 hr at 37°C with 250 rpm shaking. After incubation, the E. coli were plated on agar plates containing LB media + 25 µg/ml ampicillin or kanamycin, and incubated overnight at 37°C. Selected colonies were screened using the synthetic primers specified for Arm A.
Materials and Methods

BAC
The plasmid DNA was isolated from positive clones after overnight culture in 10 mL of LB containing media + 25 µg/ml ampicillin at 275 rpm and 37°C. Project Overview. There is no system currently in place to study the mechanism of the GH regulation of IGF-1 via Stat5b. The goal of this project ( Figure 5) is to create a model system in which this mechanism can be closely studied. This will involve transfecting the about 250 kb of the IGF-1 gene locus into a cell line and stabilizing it by making it essential to the cell. To do this, antibiotic resistance to Geneticin (G418) will be added to the gene prior to transfection. The selection pressure will be applied throughout the experiment to ensure only those cells containing the integrated transgene are able to survive the treatment. Once this model system is created, it will allow for a system in which experiments to be conducted to study the Stat5b mediated GH regulation of IGF-1 transcription.
Addition of selectable marker. Before the BAC can be placed into cell culture, it must be modified so cells which integrated the BAC into their genomic DNA can be distinguished from the cells which did not. The most efficient way to do this is by addition of a selectable marker which is a gene that allows for resistance against antibiotics, in this case Neomycin, which is complete with its own prokaryotic and eukaryotic promoters.
These promoters allow the antibiotic selection to be used in both E. coli and Cos7 cell culture. Inserting this gene into the BAC was achieved by recombination based gene engineering, or recombineering ( Figure 6 ). Recombineering is a method using modified E. coli strains which contain genes, exo, bet and gam from λ-phage technology. These Figure 6 . Recombineering. The process of recombineering involves selecting the location of the gene insertion, amplifying the region by PCR and inserting them around the gene of interest. By adding the isolated cassette to the BAC in the special strain of E. coli which contains the genes required for foreign DNA insertion, the new gene can be inserted.
genes are under the control of a temperature sensitive promoter which when activated, produces proteins that allow foreign DNA to be inserted by homology into another DNA fragment. Homology arms, small DNA fragments made from the BAC from the desired location for the insert of the gene, are inserted into either side of the gene creating a cassette ( Figure 7) . The cassette is then recombined into the BAC providing antibiotic Figure 7 . Neomycin cassette. The neomycin cassette is made up of its two promoters, one that is functional in prokaryotic organisms (pGK) and the other functional in eukaryotic organisms (pGH). Surrounding the gene are the A and B homology arms (Blue).
resistance to Geneticin (G418) when in cell culture and Neomycin with in E. coli. When this BAC is modified in E. coli, the clones can be grown on neomycin selection plates and only the ones containing this marker will survive the treatment. The process is similar in cell culture because only the cells which integrate the BAC into their genome will survive the G418 treatment. The successful integration of the gene be confirmed after the selection step by screening for the gene by PCR. The PCR screen in Figure 8B shows the successful integration of the neomycin gene into the BAC using primers oriented as in Figure 8A . can then begin to take the next steps to confirm the system works by stimulating it with GH. If the system works, IGF-1 will be produced and we will be able to start designing experiments to study the mechanism of GH regulated IGF-1 transcription. From this system we can study the amount of IGF-1 protein produced compared to normal levels of IGF-1 protein production when stimulated by GH. The structure and the amount of mRNA can also be studied. We can compare the sequences of the mRNA produced to Future Implications. This model system is vital to answering questions about the mechanism by which Stat5b mediated GH regulation of IGF-1 transcription functions.
Once this system can be established further modification of this system may help to answer different questions. A long term goal of this project would be isolate the key Stat5b site(s) needed to promote transcription. These sites could be isolated using a method known as chromosome immunoprecipation (ChIP) which shows protein-DNA interactions. After confirming the sites which Stat5b binds, the all the sites can be either removed completely, all can be removed except one, or only one site can be removed at a time. After the levels of IGF-1 transcription have been established by the native system, this data can be used to compare to other systems in which the Stat5b binding sites are removed or transclocated. There could be no change in the transcription levels indicating the removed site may not be the key site or the amount of transcription may be reduced indicating it may be a part of multiple sites required for transcription. It could also completely stop the production of IGF-1 protein meaning that it may be a critical site. If the important site(s) can be narrowed down, the structure of both the protein and the mRNA can be compared to the native model system. It is possible the removal of the sites may have an effect on the structure of the IGF-1 proteins and mRNA. The long distance interactions between the site and the promoter can also examined to see if the interaction still occurs, or if the site being removed or transclocated has an effect on how the DNA conforms upon GH stimulation. As has been described, if this system can be established, many questions about this mechanism can be studied.
Conclusion
The GH regulation IGF-1 transcription is a process integral to growth, tissue repair, and metabolism. The exact mechanism by which Stat5b mediates this process is still not clear though it has been established is critical to initiate transcription by previous research.
Since there is no model system in place to study this mechanism, one will be created which will provide the material necessary to closely examine Stat5b. A BAC containing the IGF-1 gene will be modified with an antibiotic selection marker, linearized, and inserted into a cell line. This cell line will select for the integrated gene using antibiotic selection and a stable cell line will be created. If this model system can be established, questions about the mechanism of Stat5b interaction with the DNA can be examined to help elucidate the pathway. Longer term goals include removing the putative Stat5b binding sites from the BAC to help isolate the most important sites. If successful, this project can help to answer larger questions about the role of Stat5b in GH/IGF-1 growth axis in humans.
